Dogwood Therapeutics Q3 EPS $(0.14) Beats $(0.15) Estimate, Sales $100.000K
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Beats
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 98.29 percent increase over losses of $(8.20) per share
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 98.29 percent increase over losses of $(8.20) per share from the same period last year. The company reported $100.000 thousand in sales this quarter.